Y030-8907 Screening compound: N-(5-benzyl-1,3,4-thiadiazol-2-yl)-2-(thiophen-2-yl)acetamide

Y030-8907 Screening compound: N-(5-benzyl-1,3,4-thiadiazol-2-yl)-2-(thiophen-2-yl)acetamide
Y030-8907 Screening compound: N-(5-benzyl-1,3,4-thiadiazol-2-yl)-2-(thiophen-2-yl)acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound Y030-8907
N-(5-benzyl-1,3,4-thiadiazol-2-yl)-2-(thiophen-2-yl)acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

Y030-8907

Molecular Formula

C15H13N3OS2 (C15 H13 N3 OS2)

Compound Name

N-(5-benzyl-1,3,4-thiadiazol-2-yl)-2-(thiophen-2-yl)acetamide

IUPAC name

N-(5-benzyl-134-thiadiazol-2-yl)-2-(thiophen-2-yl)acetamide

SMILES

O=C(Cc1cccs1)Nc1nnc(Cc2ccccc2)s1

InChI

InChI=1S/C15H13N3OS2/c19-13(10-12-7-4-8-20-12)16-15-18-17-14(21-15)9-11-5-2-1-3-6-11/h1-8H,9-10H2,(H,16,18,19)

InChI Key

JDAKJOKHVHDECZ-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD03930145

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

315.42

Hydrogen Bond Acceptors Count

4.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

4

Partition Coefficient, logP

3.050

Distribution Coefficient, logD

3.027

Water Solubility, LogSw

-3.29

Polar Surface Area

47.903

Acid Dissociation Constant (pKa)

8.66

Base Dissociation Constant (pKb)

-4.31

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

13.30

Y030-8907 in Drug Discovery

Included in Screening Libraries

CNS targets activity set (6557 compounds)

Human Receptors Annotated Library (5376 compounds)

Selective Target Activity Profiling Library (14702 compounds)

Therapeutical Diversity Annotated Library (7563 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Targets:
  • Phosphatases

References: we are preparing a list of scientific research reports with Y030-8907 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound Y030-8907?
Check Price and Availability of Y030-8907, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of Y030-8907 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for Y030-8907
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for Y030-8907
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of Y030-8907 available by request